patent/EP-0266504-A3

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H19-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-167 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7076 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042
filingDate	1987-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	1990-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-0266504-A3
titleOfInvention	Use of N6-[(1,2-dihydro-1-acenaphthylenyl) methyl]-adenosine in the preparation of pharmaceutical compounds for treating congestive heart failure
abstract	This application refers to the use of N⁶-[(1,2-dihydro-1-nacenaphthylenyl)-methyl]adenosine or a pharmaceutically nacceptable salt thereof for the preparation of pharmaceuticals nfor treating congestive heart failure.
priorityDate	1986-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0179631-A2
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235642168 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID235642164 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68114917 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68114916 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413245416

Total number of triples: 25.